NDC 31722-704

Valacyclovir

Valacyclovir

Valacyclovir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is Valacyclovir Hydrochloride.

Product ID31722-704_08e1aac2-b315-4f41-855d-834d4ff197bc
NDC31722-704
Product TypeHuman Prescription Drug
Proprietary NameValacyclovir
Generic NameValacyclovir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2015-05-25
Marketing CategoryANDA / ANDA
Application NumberANDA203047
Labeler NameCamber Pharmaceuticals, Inc.
Substance NameVALACYCLOVIR HYDROCHLORIDE
Active Ingredient Strength500 mg/1
Pharm ClassesDNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 31722-704-01

100 TABLET, FILM COATED in 1 BOTTLE (31722-704-01)
Marketing Start Date2015-05-25
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 31722-704-30 [31722070430]

Valacyclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203047
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-05-25

NDC 31722-704-90 [31722070490]

Valacyclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203047
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-05-25

NDC 31722-704-01 [31722070401]

Valacyclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203047
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-05-25

NDC 31722-704-32 [31722070432]

Valacyclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203047
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-05-25

NDC 31722-704-05 [31722070405]

Valacyclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203047
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-05-25

NDC 31722-704-31 [31722070431]

Valacyclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203047
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-05-25

NDC 31722-704-60 [31722070460]

Valacyclovir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA203047
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-05-25

Drug Details

Active Ingredients

IngredientStrength
VALACYCLOVIR HYDROCHLORIDE500 mg/1

OpenFDA Data

SPL SET ID:7f5e96e0-534c-47a5-bb79-926088afc73c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313564
  • 313565
    • UPC Code
  • 0331722704304
  • 0331722705301

    • Pharmacological Class

    • DNA Polymerase Inhibitors [MoA]
    • Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
    • Nucleoside Analog [EXT]

    Medicade Reported Pricing

    31722070490 VALACYCLOVIR HCL 500 MG TABLET

    Pricing Unit: EA | Drug Type:

    31722070430 VALACYCLOVIR HCL 500 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Valacyclovir" or generic name "Valacyclovir"

    NDCBrand NameGeneric Name
    0093-7258ValacyclovirValacyclovir
    0093-7259ValacyclovirValacyclovir
    31722-704ValacyclovirValacyclovir
    31722-705ValacyclovirValacyclovir
    43063-771ValacyclovirValacyclovir
    43353-883ValacyclovirValacyclovir Hydrochloride
    50090-2510ValacyclovirValacyclovir
    50090-2575ValacyclovirValacyclovir
    50436-0704ValacyclovirValacyclovir
    50436-7050ValacyclovirValacyclovir
    51407-107ValacyclovirValacyclovir
    51407-108ValacyclovirValacyclovir
    51660-904VALACYCLOVIRVALACYCLOVIR HYDROCHLORIDE
    51660-905VALACYCLOVIRVALACYCLOVIR HYDROCHLORIDE
    52343-051Valacyclovirvalacyclovir hydrochloride
    52343-052Valacyclovirvalacyclovir hydrochloride
    55700-913ValacyclovirValacyclovir
    60760-469ValacyclovirValacyclovir
    61919-066ValacyclovirValacyclovir
    61919-515VALACYCLOVIRVALACYCLOVIR
    61919-919ValacyclovirValacyclovir
    68071-3135ValacyclovirValacyclovir
    68071-3276ValacyclovirValacyclovir
    68071-3372ValacyclovirValacyclovir
    68071-4805ValacyclovirValacyclovir
    68382-226ValacyclovirValacyclovir
    68382-225ValacyclovirValacyclovir
    70518-0323ValacyclovirValacyclovir
    70934-106ValacyclovirValacyclovir
    71335-0630ValacyclovirValacyclovir
    63187-950ValacyclovirValacyclovir
    63304-904ValacyclovirValacyclovir
    63304-905ValacyclovirValacyclovir
    65841-630ValacyclovirValacyclovir
    65841-629ValacyclovirValacyclovir
    63629-7958ValacyclovirValacyclovir
    70518-2402ValacyclovirValacyclovir
    68071-3332ValacyclovirValacyclovir
    0378-4275Valacyclovir Hydrochloridevalacyclovir
    0378-4276Valacyclovir Hydrochloridevalacyclovir
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.